Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Maayan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Blood Cells, Molecules & Diseases|July 24, 2014
Hypothesis: Concordance of Gaucher disease and large granular lymphocytic leukemia has biological plausibilityRosa Ruchlemer, Hannah Maayan, Deborah Elstein, et al.
The Israel Medical Association Journal : IMAJ|October 14, 2008
Persistent chylothorax in Behcet's disease treated with a blood patchHannah Maayan, Gabriel Izbicki, Judith Heyd, et al.
Scandinavian Journal of Infectious Diseases|March 15, 2005
Infective endocarditis due to Moraxella lacunata: report of 4 patients and review of published cases of Moraxella endocarditisHannah Maayan, Ronit Cohen-Poradosu, Efraim Halperin, et al.
Journal of Thrombosis and Haemostasis : JTH|June 9, 2021
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccineHannah Maayan, Ilya Kirgner, Odit Gutwein, et al.
Blood Cells, Molecules & Diseases|November 4, 2011
Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: early Access Program results from JerusalemDeborah Elstein, Gheona Altarescu, Hannah Maayan, et al.
Annals of Hematology|October 14, 2014
Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantationMaya Koren-Michowitz, Hannah Maayan, Arie Apel, et al.
Journal of Inherited Metabolic Disease|August 2, 2018
Improvement in bone marrow infiltration in patients with type I Gaucher disease treated with taliglucerase alfaAri Zimran, Tama Dinur, Shoshana Revel-Vilk, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Blood Cells, Molecules & Diseases|July 24, 2014
Hypothesis: Concordance of Gaucher disease and large granular lymphocytic leukemia has biological plausibilityRosa Ruchlemer, Hannah Maayan, Deborah Elstein, et al.
The Israel Medical Association Journal : IMAJ|October 14, 2008
Persistent chylothorax in Behcet's disease treated with a blood patchHannah Maayan, Gabriel Izbicki, Judith Heyd, et al.
Scandinavian Journal of Infectious Diseases|March 15, 2005
Infective endocarditis due to Moraxella lacunata: report of 4 patients and review of published cases of Moraxella endocarditisHannah Maayan, Ronit Cohen-Poradosu, Efraim Halperin, et al.
Journal of Thrombosis and Haemostasis : JTH|June 9, 2021
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccineHannah Maayan, Ilya Kirgner, Odit Gutwein, et al.
Blood Cells, Molecules & Diseases|November 4, 2011
Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: early Access Program results from JerusalemDeborah Elstein, Gheona Altarescu, Hannah Maayan, et al.
Annals of Hematology|October 14, 2014
Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantationMaya Koren-Michowitz, Hannah Maayan, Arie Apel, et al.
Journal of Inherited Metabolic Disease|August 2, 2018
Improvement in bone marrow infiltration in patients with type I Gaucher disease treated with taliglucerase alfaAri Zimran, Tama Dinur, Shoshana Revel-Vilk, et al.
Pageof 1